| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9872035 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 6 Pages |
Abstract
Conclusions: Patients who present with hematologic disease only at the time of HSCT have a low risk of CNS recurrence after TBI regardless of the use of a cranial boost, suggesting that a cranial boost may not be necessary in these patients.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Brian M. M.D., Daniel M.D., Ph.D., Thomas M. Ph.D., John M.D., Joseph M.D., Gregory M.D., Raymond M.D., Lori J. M.D.,